These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 425668)

  • 41. [On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
    Seghezzi R; Borri P; Pedroni G
    Minerva Med; 1968 Dec; 59(99):5458-65. PubMed ID: 5718833
    [No Abstract]   [Full Text] [Related]  

  • 42. [Vasodilator treatment in arteriopathies of the lower limb].
    Sicard A; Natali J; Lacombe M
    Therapeutique; 1968 Nov; 44(9):546-7. PubMed ID: 5759645
    [No Abstract]   [Full Text] [Related]  

  • 43. [Phonoangiographic demonstration of the effect of various vasodilators on patients with peripheral obliterans arteriosclerosis].
    Meciani L; Tealdi D; Santa A; Ricci G
    Minerva Cardioangiol; 1969 Nov; 17(11):942-7. PubMed ID: 5404822
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experiences with a new xanthine derivative in central and peripheral blood circulation disorders].
    Hirsch W; Woschée GJ
    Ther Ggw; 1971 Nov; 110(11):1668 passim. PubMed ID: 5158649
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic tactics in pregangrenous phase of obliterating diseases of arteries of the extremities].
    Krakovskiĭ NI
    Sov Med; 1973 Oct; 36(10):7-12. PubMed ID: 4789219
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of peripheral circulation disorders of lower extremities with Flunarizine and papaverine].
    Brugmans J; Jageneau A; Adriaensen H
    Med Welt; 1977 Jun; 28(23):1056-64. PubMed ID: 886962
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 48. The natural history of arteriosclerosis in the lower extremities II: A plethysmographic study of non-occlusive arteriosclerotic disease in the lower limbs.
    Ulrich J; Siggaard-Andersen J
    Dan Med Bull; 1975 Apr; 22(4):136-40. PubMed ID: 1149500
    [No Abstract]   [Full Text] [Related]  

  • 49. [The problem of medicamentous and operative vasodilation in obliterative arteriosclerosis of the lower extremities].
    STEFANICS J; PAPP S; GORGO P; RANKY L
    Magy Seb; 1955 Feb; 8(1):41-52. PubMed ID: 14382760
    [No Abstract]   [Full Text] [Related]  

  • 50. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G; Tallarida G; Baldoni F; Raimondi G; Grimaldi I; Sangiorgi M
    Clin Ter; 1985 Jul; 114(1):3-26. PubMed ID: 2864161
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dependence of the pharmacodynamics of papaverine on the initial state of circulatory system and external respiration in patients with arteriosclerotic myocardiosclerosis].
    Zubarev VV; Dotsenko IaN
    Vrach Delo; 1973 Mar; 3():51-5. PubMed ID: 4733032
    [No Abstract]   [Full Text] [Related]  

  • 52. [Study of peripheral blood circulation using automated occlusion plethysmography].
    Mukharliamov NM; Sazonova LN; Pushkar' IuT
    Ter Arkh; 1981; 53(12):3-6. PubMed ID: 7336338
    [No Abstract]   [Full Text] [Related]  

  • 53. [Conservative therapy of chronic arterial occlusions in the extremities].
    Nobbe F
    Verh Dtsch Ges Inn Med; 1972; 78():520-33. PubMed ID: 4665689
    [No Abstract]   [Full Text] [Related]  

  • 54. [Collateral circulation of leg in arteriosclerotic vasculopathies in young and old patients. Findings on the femoral circulation].
    Marchisio V; Romagnoli R; Vendrame L; Giovannini G; Fontana C
    Nunt Radiol; 1968 Oct; 34(10):1091-109. PubMed ID: 5745108
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pros and cons of vasodilator therapy in obliterative vascular diseases of the lower limbs].
    Thulesius O
    Lakartidningen; 1966 Oct; 63(43):4089-96. PubMed ID: 5977628
    [No Abstract]   [Full Text] [Related]  

  • 57. [Long-term results of the treatment of aorto-iliac and peripheral arteriosclerotic arteriopathies].
    Romana A; Ovaleo Pandolfo E; Botti E
    Minerva Chir; 1975 Apr; 30(7):442-5. PubMed ID: 48213
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapeutic aspects of arteriosclerosis].
    Ciammaichella A
    Clin Ter; 1976 Aug; 78(4):295-301. PubMed ID: 1009756
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of the action of Halidor on the circulation in the extremities].
    Solti F
    Orv Hetil; 1968 May; 109(21):Suppl:21-4. PubMed ID: 5720716
    [No Abstract]   [Full Text] [Related]  

  • 60. Cilostazol increases skin perfusion pressure in severely ischemic limbs.
    Miyashita Y; Saito S; Miyamoto A; Iida O; Nanto S
    Angiology; 2011 Jan; 62(1):15-7. PubMed ID: 20504836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.